PAX7 and facioscapulohumeral muscular dystrophy: In a longitudinal study of FSHD muscle via MRI, transcriptomics and histology (Wong et al, 2020), PAX7 target gene score repression was significantly associated with FSHD patient progression over one year (Banerji, 2020).